Supplementary Figure S2 from ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Cancer Genomics and Diagnostics
PARP inhibition in cancer therapy
Endometrial and Cervical Cancer Treatments
Publication details
- Publication date
- 1 April 2026
- Language
- EN